Blue Jet Healthcare lists at 10% premium on bourses; Should you hold or book profit-
时间:2024-06-26 17:01:31 阅读(143)
Blue Jet Healthcare shares listed at 9.82 % premium over IPO price on bourses amid weak domestic market. The share debuted at Rs 380 on the NSE and at Rs 359.90 on the BSE, as compared to the issue price of Rs 346. The investors have made a profit of Rs 34 per share as the scrip gave nearly 10% return to investors on the listing.
“Blue Jet Healthcare made its debut on the stock markets today, by listing at Rs 380 per share, a premium of around 10% to its IPO price of Rs 346. The IPO was subscribed 7.95 times, which is a good subscription level. Blue Jet Healthcare is a manufacturer of contrast media intermediates and high-intensity sweeteners. The company has a strong competitive advantage due to its high entry barriers and long-term relationships with multinational customers. The company’s financial performance is also strong, with consistent revenue and profit growth in recent years. Overall, the listing of Blue Jet Healthcare was a success. The company’s strong fundamentals and good subscription levels were positive factors for this. Investors may hold it by keeping a stop loss at Rs 340,” said Shivani Nyati, Head of Wealth, Swastika Investmart.
The IPO comprised an offer-for-sale (OFS), with promoters offloading 24,285,160 shares of Rs 2 aggregating up to Rs 840.27 crore. For potential investors, the bidding started at a minimum of 43 equity shares, with subsequent bids in multiple lots of 43 equity shares each. The minimum amount of investment required by retail investors was Rs 14,878.
猜你喜欢
- Avalon Technologies IPO Day 1- Retail investors bid 0
- Bajaj Auto Q4FY23 net profit falls 2
- Bank Nifty, PSU Bank, Private Bank, Fin Nifty jump; Almost all banking stocks trade in green, HDFC Bank up 2%
- Azim Premji and Yasmeen Premji- The impressive joint net worth of one of India’s most prosperous couples
- Bank Nifty settles above 44k, posts fresh record close
- Bank Nifty aims for 42700 after witnessing an extension in downtrend; BSE Sensex likely to fall
- Ban on futures trade of agri items must go- NCDEX chief
- Bank stocks attractive, says HDFC MF’s Prashant Jain; finds D-Street valuations reasonable now
- Dollar plunges as US inflation cools-off; rupee sees volatility but remains range-bound on equity inflows, RBI buying